4DMedical Expands U.S. Presence with Landmark Partnership with IPOC

4DMedical Limited (ASX: 4DX), a pioneer in respiratory imaging, has signed a commercial contract with Imaging Partners of Orange County (IPOC) in the U.S. to provide its advanced CT LVAS and LDAf(Lung Density Analysis) scans. The partnership, running until March 2026, marks a significant milestone following the CMS reimbursement approval for CT LVAS, advancing 4DMedical’s commercial footprint. IPOC, with 15 radiologists across five locations in Orange County, offers cutting-edge diagnostic services in a region renowned for healthcare innovation. 4DMedical’s technology combines structural and functional lung analysis, aiding in earlier and more precise diagnosis of respiratory diseases.

This deal builds on a recent collaboration with the California Thoracic Society, which generated significant interest in the technology for diagnosing unexplained dyspnoea. CEO Andreas Fouras highlighted the growing U.S. demand for their solutions, driven by educational initiatives and partnerships. The agreement underscores 4DMedical’s mission to revolutionize respiratory diagnostics globally.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com